ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
1.12
0.00
(0.00%)
Closed November 19 4:12PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.12
Bid
0.60
Ask
0.70
Volume
-
0.00 Day's Range 0.00
1.12 52 Week Range 1.12
Previous Close
1.12
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

IMV Latest News

Horizon Technology Finance Announces First Quarter 2023 Financial Results

Horizon Technology Finance Announces First Quarter 2023 Financial Results PR Newswire FARMINGTON, Conn., May 2, 2023 - First Quarter 2023 Net Investment Income per Share of $0.46; NAV per Share...

Suspension de la négociation par l'OCRCVM - IMV

Suspension de la négociation par l'OCRCVM - IMV Canada NewsWire TORONTO, le 1er mai 2023 TORONTO, le 1er mai 2023 /CNW/ - L'OCRCVM a suspendu la négociation des titres suivants...

IIROC Trading Halt - IMV

IIROC Trading Halt - IMV Canada NewsWire TORONTO, May 1, 2023 TORONTO, May 1, 2023 /CNW/ - The following issues have been halted by IIROC: Company: IMV Inc.  TSX Symbol: IMV  All Issues:...

TMX Group, IMV, C-Suite at The Open

TMX Group, IMV, C-Suite at The Open Canada NewsWire TORONTO, Dec. 9, 2020 TORONTO, Dec. 9, 2020 /CNW/ - Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his company's story in an interview with TMX...

IMV fournit une mise à jour sur son programme de vaccin COVID-19

Sélectionnée par le gouvernement canadien pour recevoir un financement supplémentaire, portant le soutien à un total de 10 millions de dollars à ce jour pour le développement clinique et la...

IMV to Participate at Four Upcoming Investor Conferences

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious...

IMV Inc. Announces Second Quarter 2020 Financial Results

Rapidly progressing DPX-COVID-19, including Health Canada agreement on Phase 1 clinical study design protocol, with preliminary results expected in fall 2020 Confirmed $4.75M of non-dilutive...

IMV reçoit des subventions de la part d’agences gouvernementales pour la phase 1 du développement clinique du vaccin cont...

Ces subventions d’un total de 4,75 millions soutiendront la fabrication du vaccin et l’étude clinique de phase 1 IMV Inc. (Nasdaq: IMV; TSX: IMV), une société biopharmaceutique (la « Société »...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1001.121.121.1200CS
4001.121.121.1200CS
12001.121.121.1200CS
26001.121.121.1200CS
52001.121.121.1200CS
156-21.98-95.151515151523.1240.622683210.35783068CS
260-31.68-96.585365853732.892.50.628028338.17603389CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NCFNorthcliff Resources Ltd
$ 0.04
(60.00%)
364.6k
IAUi80 Gold Corp
$ 0.63
(28.57%)
3.76M
YRBYorbeau Resources Inc
$ 0.05
(25.00%)
233k
PRYMPrime Mining Corp
$ 1.55
(20.16%)
896.13k
AOTAscot Resources Ltd
$ 0.20
(17.65%)
3.06M
NUMINuminus Wellness Inc
$ 0.035
(-36.36%)
2.9M
RTGRTG Mining Inc
$ 0.025
(-28.57%)
6k
DII.ADorel Industries Inc
$ 4.00
(-20.00%)
400
LEVLion Electric Company
$ 0.40
(-16.67%)
850.36k
BABYElse Nutrition Holdings Inc
$ 0.025
(-16.67%)
40.64k
ENBEnbridge Inc
$ 59.65
(0.42%)
33.09M
SUSuncor Energy Inc
$ 57.18
(0.32%)
13.01M
CNQCanadian Natural Resources Ltd
$ 47.17
(1.20%)
12.27M
MFCManulife Financial Corporation
$ 45.33
(-1.56%)
9.45M
GWOGreat West Lifeco Inc
$ 49.18
(0.86%)
8.23M

Your Recent History

Delayed Upgrade Clock